Changes in metabolic markers -LSB- total alkaline phosphatase ( AP ) , bone-specific AP and fibroblast growth factor-@ ( FGF-@ ) -RSB- and the proportion of patients in each treatment group who achieved an iPTH level of @-@ pg/mL during Weeks @ , @ and @-@ as a composite value were evaluated .